Pulmonary Trials

  • PULM: Pulmonary Arterial Hypertension - ARTISAN

    The primary objective of this study is to assess the effect of early and rapid treprostinil therapy for mean pulmonary artery pressure (mPAP) reduction to improve right ventricular (RV) function and reverse RV remodeling in participants with pulmonary arterial hypertension (PAH).

Search This Section